T1	PROC 46 56	Evaluación
#1	AnnotatorNotes T1	C1261322; Evaluation procedure; Health Care Activity
T2	DISO 87 91	asma
#2	AnnotatorNotes T2	C0004096; Asthma; Disease or Syndrome
T3	CHEM 60 69	Dupilumab
#3	AnnotatorNotes T3	C3660996; dupilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	PROC 148 227	Estudio de búsqueda de dosis, aleatorizado, doble ciego, controlado con placebo
T5	PROC 905 909	FEV1
#4	AnnotatorNotes T5	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
T6	CHEM 793 797	LABA
#5	AnnotatorNotes T6	[long-acting beta agonists]
T7	DISO 268 272	asma
#6	AnnotatorNotes T7	C0004096; Asthma; Disease or Syndrome
T8	DISO 330 334	Asma
#7	AnnotatorNotes T8	C0004096; Asthma; Disease or Syndrome
T9	PROC 378 396	diagnóstico médico
T10	DISO 400 404	asma
#8	AnnotatorNotes T10	C0004096; Asthma; Disease or Syndrome
T11	PROC 850 877	Volumen espiratorio forzado
#9	AnnotatorNotes T11	C1306036; Forced expiratory volume procedure; Diagnostic Procedure
T12	DISO 525 529	asma
#10	AnnotatorNotes T12	C0004096; Asthma; Disease or Syndrome
T13	PROC 605 616	Tratamiento
#11	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	CHEM 665 669	LABA
#12	AnnotatorNotes T14	[long-acting beta agonists]
T15	CHEM 697 722	propionato de fluticasona
T16	PROC 1002 1016	aleatorización
#13	AnnotatorNotes T16	C0034656; Randomization; Research Activity
T17	PROC 1366 1390	consentimiento informado
#14	AnnotatorNotes T17	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T18	PROC 1230 1234	FEV1
#15	AnnotatorNotes T18	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
T19	CHEM 661 664	ICS
#16	AnnotatorNotes T19	C4020618; Anti-inflammatories, Inhaled Corticosteroids; Pharmacologic Substance
T20	PROC 1255 1270	Hospitalización
#17	AnnotatorNotes T20	C0019993; Hospitalization; Health Care Activity
T21	DISO 1332 1336	asma
#18	AnnotatorNotes T21	C0004096; Asthma; Disease or Syndrome
T22	DISO 1450 1489	Enfermedad pulmonar obstructiva crónica
#19	AnnotatorNotes T22	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T23	DISO 1491 1495	EPOC
#20	AnnotatorNotes T23	C0024117; Chronic Obstructive Airway Disease; Disease or Syndrome
T24	DISO 1505 1528	enfermedades pulmonares
#21	AnnotatorNotes T24	C0024115; Lung diseases; Disease or Syndrome
T25	DISO 1543 1551	enfisema
#22	AnnotatorNotes T25	C0013990; Pathological accumulation of air in tissues; Pathologic Function | C0034067; Pulmonary Emphysema; Disease or Syndrome
T26	DISO 1553 1581	fibrosis pulmonar idiopática
#23	AnnotatorNotes T26	C1800706; Idiopathic Pulmonary Fibrosis; Disease or Syndrome
T27	DISO 1583 1605	síndrome Churg-Strauss
#24	AnnotatorNotes T27	C0008728; Eosinophilic granulomatosis with polyangiitis; Disease or Syndrome
T28	DISO 1607 1643	aspergilosis broncopulmonar alérgica
#25	AnnotatorNotes T28	C0004031; Aspergillosis, Allergic Bronchopulmonary; Disease or Syndrome
T29	PROC 1661 1688	pruebas de función pulmonar
#26	AnnotatorNotes T29	C0024119; Pulmonary function tests; Diagnostic Procedure
T30	PROC 1691 1711	Radiografía de tórax
#27	AnnotatorNotes T30	C0039985; Plain chest X-ray; Diagnostic Procedure
T31	DISO 1871 1875	asma
#28	AnnotatorNotes T31	C0004096; Asthma; Disease or Syndrome
T32	DISO 1878 1885	Fumador
#29	AnnotatorNotes T32	C0337664; Smoker; Finding
T33	DISO 1969 1983	Fumador previo
#30	AnnotatorNotes T33	C0337671; Former smoker; Finding
T34	DISO 2004 2014	tabaquismo
#31	AnnotatorNotes T34	C0040336; Tobacco Use Disorder; Mental or Behavioral Dysfunction | C0425291; Tobacco smoking consumption; Finding | C1306274; Tabagism; Mental or Behavioral Dysfunction
T35	CHEM 241 250	Dupilumab
#32	AnnotatorNotes T35	C3660996; dupilumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T36	DISO 1064 1068	asma
#33	AnnotatorNotes T36	C0004096; Asthma; Disease or Syndrome
T37	ANAT 1461 1469	pulmonar
#34	AnnotatorNotes T37	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T38	ANAT 1518 1528	pulmonares
#35	AnnotatorNotes T38	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T39	ANAT 1562 1570	pulmonar
#36	AnnotatorNotes T39	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T40	ANAT 1680 1688	pulmonar
#37	AnnotatorNotes T40	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T41	ANAT 1706 1711	tórax
#38	AnnotatorNotes T41	C0817096; Chest; Body Location or Region | C1269614; Entire thorax; Body Part, Organ, or Organ Component
T42	DISO 1831 1858	enfermedad(es) pulmonar(es)
T43	DISO 1917 1922	fumar
#39	AnnotatorNotes T43	C0556394; Smokes drugs; Finding
T44	CHEM 729 732	ICS
#40	AnnotatorNotes T44	C4020618; Anti-inflammatories, Inhaled Corticosteroids; Pharmacologic Substance
T45	CHEM 789 792	ICS
#41	AnnotatorNotes T45	C4020618; Anti-inflammatories, Inhaled Corticosteroids; Pharmacologic Substance
T46	PROC 1036 1068	cuestionario de control del asma
#42	AnnotatorNotes T46	C4706266; Assessment using Asthma Control Questionnaire; Health Care Activity
T47	Date 13 17	2013
T48	LIVB 73 82	pacientes
#43	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T50	LIVB 254 263	pacientes
#44	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T52	LIVB 361 370	Pacientes
#45	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T54	Frequency 746 762	dos veces al día
T55	Dose 768 785	una dosis estable
T59	LIVB 1337 1346	Pacientes
#46	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1419 1428	Pacientes
#47	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T61	Age 1429 1447	menores de 18 años
T62	Duration 1482 1489	crónica
#48	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	Duration 1715 1727	los 12 meses
T64	Neg_cue 1863 1865	no
T65	Date 1886 1892	actual
T66	Duration 1933 1944	los 6 meses
T49	Duration 447 469	más o igual a 12 meses
T51	Date 570 574	2009
T53	Dose 631 657	dosis de moderadas a altas
T67	Dose 671 693	sup o igual 250 microg
T68	Duration 806 825	mas o igual a 1 mes
T56	ANAT 1846 1858	pulmonar(es)
#49	AnnotatorNotes T56	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T57	PROC 1273 1309	visita médica de emergencia/urgencia
#50	AnnotatorNotes T57	C0586082; Emergency department patient visit; Health Care Activity
T58	PROC 838 844	visita
#51	AnnotatorNotes T58	C1512346; Patient Visit; Health Care Activity
T69	PROC 964 970	visita
#52	AnnotatorNotes T69	C1512346; Patient Visit; Health Care Activity
T70	PROC 981 987	visita
#53	AnnotatorNotes T70	C1512346; Patient Visit; Health Care Activity
T71	PROC 1165 1172	visitas
#54	AnnotatorNotes T71	C1512346; Patient Visit; Health Care Activity
T72	PROC 1958 1964	visita
#55	AnnotatorNotes T72	C1512346; Patient Visit; Health Care Activity
T73	PROC 1741 1760	visita de selección
#56	AnnotatorNotes T73	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T74	PROC 1769 1788	visita de selección
#57	AnnotatorNotes T74	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T75	Quantifier_or_Qualifier 845 846	1
T76	Quantifier_or_Qualifier 971 972	1
T77	Quantifier_or_Qualifier 988 989	2
T78	Quantifier_or_Qualifier 1173 1178	1 y 2
T79	Quantifier_or_Qualifier 1965 1966	1
A1	Assertion T31 Negated
A2	Status T43 History_of
A3	Status T34 History_of
A4	Status T33 History_of
#61	AnnotatorNotes T4	C4764141; Dose Finding Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#62	AnnotatorNotes T9	C0871813; medical diagnosis; Diagnostic Procedure 
#63	AnnotatorNotes T42	C0024115; Lung diseases; Disease or Syndrome
#64	AnnotatorNotes T65	C0521116; Current (present time); Temporal Concept 
T80	Quantifier_or_Qualifier 276 286	controlada
A5	Assertion T80 Negated
T81	Quantifier_or_Qualifier 95 105	controlada
A6	Assertion T81 Negated
T82	Neg_cue 92 94	no
T83	Neg_cue 273 275	no
T84	Neg_cue 405 407	no
T85	Quantifier_or_Qualifier 408 418	controlada
A7	Assertion T85 Negated
T86	Observation 1898 1922	cese del hábito de fumar
#58	AnnotatorNotes T86	C0425310; Stopped smoking; Finding
R1	Experiences Arg1:T48 Arg2:T3	
R2	Experiences Arg1:T48 Arg2:T2	
R3	Negation Arg1:T82 Arg2:T81	
R4	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T81	
T87	Quantifier_or_Qualifier 109 125	moderada a grave
#59	AnnotatorNotes T87	C1299393; Moderate to severe; Qualitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T87	
R6	Experiences Arg1:T48 Arg2:T1	
R7	Experiences Arg1:T50 Arg2:T35	
R8	Experiences Arg1:T50 Arg2:T7	
R9	Negation Arg1:T83 Arg2:T80	
T88	Quantifier_or_Qualifier 290 306	moderada a grave
#60	AnnotatorNotes T88	C1299393; Moderate to severe; Qualitative Concept
R10	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T88	
R11	Experiences Arg1:T52 Arg2:T10	
R12	Negation Arg1:T84 Arg2:T85	
R13	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T85	
T89	Quantifier_or_Qualifier 422 438	moderada a grave
#65	AnnotatorNotes T89	C1299393; Moderate to severe; Qualitative Concept
R14	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T89	
R15	Has_Duration_or_Interval Arg1:T10 Arg2:T49	
R16	Experiences Arg1:T52 Arg2:T12	
R17	Used_for Arg1:T19 Arg2:T13	
R18	Used_for Arg1:T14 Arg2:T13	
R19	Has_Dose_or_Strength Arg1:T19 Arg2:T53	
R21	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T75	
R22	Has_Quantifier_or_Qualifier Arg1:T69 Arg2:T76	
R23	Has_Quantifier_or_Qualifier Arg1:T70 Arg2:T77	
T90	Result_or_Value 911 957	entre el 40 y el 80% del valor normal previsto
R24	Has_Result_or_Value Arg1:T5 Arg2:T90	
R25	Has_Result_or_Value Arg1:T11 Arg2:T90	
R26	Overlap Arg1:T5 Arg2:T69	
R27	Overlap Arg1:T11 Arg2:T69	
R28	Overlap Arg1:T11 Arg2:T70	
R29	Overlap Arg1:T5 Arg2:T70	
R30	Before Arg1:T11 Arg2:T16	
R31	Before Arg1:T5 Arg2:T16	
T91	Result_or_Value 1142 1157	sup o igual 1,5
R32	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T78	
R34	Has_Dose_or_Strength Arg1:T14 Arg2:T53	
#66	AnnotatorNotes T15	C0117996; fluticasone propionate; Organic Chemical · Pharmacologic Substance
R35	Has_Dose_or_Strength Arg1:T15 Arg2:T67	
T92	CONC 729 744	ICS equivalente
R20	Used_for Arg1:T44 Arg2:T13	
R36	Has_Frequency Arg1:T15 Arg2:T54	
R37	Has_Dose_or_Strength Arg1:T45 Arg2:T55	
R38	Has_Dose_or_Strength Arg1:T6 Arg2:T55	
R39	Has_Duration_or_Interval Arg1:T45 Arg2:T68	
R40	Has_Duration_or_Interval Arg1:T6 Arg2:T68	
R41	Before Arg1:T45 Arg2:T58	
R42	Before Arg1:T6 Arg2:T58	
T93	CONC 1135 1140	ACQ-5
#67	AnnotatorNotes T93	C2919686; Asthma control questionnaire; Intellectual Product (?)
T94	CONC 1105 1133	Asthma Control Questionnaire
#68	AnnotatorNotes T94	C2919686; Asthma control questionnaire; Intellectual Product
T95	CONC 1036 1103	cuestionario de control del asma de Juniper, versión de 5 preguntas
R43	Used_for Arg1:T95 Arg2:T46	
R44	Has_Result_or_Value Arg1:T46 Arg2:T91	
R45	Has_Result_or_Value Arg1:T94 Arg2:T91	
R46	Has_Result_or_Value Arg1:T93 Arg2:T91	
T96	CONC 1181 1195;1224 1234	Reversibilidad en el FEV1
#69	AnnotatorNotes T96	C3830088; Forced Expiratory Volume in 1 Second Reversibility; Quantitative Concept
T97	Result_or_Value 1199 1223;1235 1252	al menos un 12% y 200 ml después de 200 mL
R48	Has_Result_or_Value Arg1:T96 Arg2:T97	
T98	Observation 1314 1327	empeoramiento
#70	AnnotatorNotes T98	C1457868; Worse; Finding
R47	Before Arg1:T21 Arg2:T98	
R49	Overlap Arg1:T20 Arg2:T98	
R50	Overlap Arg1:T20 Arg2:T21	
R51	Overlap Arg1:T57 Arg2:T98	
R52	Overlap Arg1:T57 Arg2:T21	
R53	Has_Age Arg1:T60 Arg2:T61	
R54	Location_of Arg1:T37 Arg2:T22	
R55	Has_Duration_or_Interval Arg1:T22 Arg2:T62	
R56	Has_Duration_or_Interval Arg1:T23 Arg2:T62	
R57	Location_of Arg1:T37 Arg2:T23	
R58	Location_of Arg1:T38 Arg2:T24	
R59	Location_of Arg1:T39 Arg2:T26	
R60	Location_of Arg1:T38 Arg2:T25	
R61	Location_of Arg1:T40 Arg2:T29	
R69	Location_of Arg1:T41 Arg2:T30	
R70	Overlap Arg1:T30 Arg2:T63	
R71	Before Arg1:T30 Arg2:T73	
R72	Overlap Arg1:T30 Arg2:T74	
R73	Location_of Arg1:T56 Arg2:T42	
R74	Negation Arg1:T64 Arg2:T31	
R75	Overlap Arg1:T42 Arg2:T31	
R78	Overlap Arg1:T32 Arg2:T65	
R79	Before Arg1:T43 Arg2:T86	
R80	Overlap Arg1:T86 Arg2:T66	
R81	Before Arg1:T86 Arg2:T72	
R82	Has_Quantifier_or_Qualifier Arg1:T72 Arg2:T79	
T99	Result_or_Value 2015 2032	> 10 paquetes-año
R83	Has_Result_or_Value Arg1:T34 Arg2:T99	
R84	Used_for Arg1:T15 Arg2:T13	
R85	Used_for Arg1:T45 Arg2:T13	
R86	Used_for Arg1:T6 Arg2:T13	
R33	Overlap Arg1:T46 Arg2:T71	
#71	AnnotatorNotes T77	C0205448; Two; Quantitative Concept
#72	AnnotatorNotes T78	C0205447; One; Quantitative Concept + C0205448; Two; Quantitative Concept
#73	AnnotatorNotes T79	C0205447; One; Quantitative Concept
#74	AnnotatorNotes T76	C0205447; One; Quantitative Concept
#75	AnnotatorNotes T75	C0205447; One; Quantitative Concept
A8	Experiencer T48 Patient
A9	Experiencer T50 Patient
A10	Experiencer T52 Patient
A11	Experiencer T59 Patient
A12	Experiencer T60 Patient
